GSK Investigational Site

Zachary, Louisiana 70791

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome, Infections, Bacterial

Studies at this site

• Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections — Completed
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) — Completed